- Home
- MTR vs TXMD Comparison
MTR vs TXMD Comparison
Compare MTR & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTR
- TXMD
- Stock Information
- Founded
- MTR 1979
- TXMD 2008
- Country
- MTR United States
- TXMD United States
- Employees
- MTR N/A
- TXMD N/A
- Industry
- MTR Oil & Gas Production
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- MTR Energy
- TXMD Health Care
- Exchange
- MTR Nasdaq
- TXMD Nasdaq
- Market Cap
- MTR 11.7M
- TXMD 10.0M
- IPO Year
- MTR N/A
- TXMD N/A
- Fundamental
- Price
- MTR $6.26
- TXMD $0.78
- Analyst Decision
- MTR
- TXMD
- Analyst Count
- MTR 0
- TXMD 0
- Target Price
- MTR N/A
- TXMD N/A
- AVG Volume (30 Days)
- MTR 3.8K
- TXMD 808.9K
- Earning Date
- MTR 01-01-0001
- TXMD 03-28-2025
- Dividend Yield
- MTR 2.86%
- TXMD N/A
- EPS Growth
- MTR N/A
- TXMD N/A
- EPS
- MTR 0.35
- TXMD N/A
- Revenue
- MTR $966,169.00
- TXMD $1,596,000.00
- Revenue This Year
- MTR N/A
- TXMD $605.07
- Revenue Next Year
- MTR N/A
- TXMD $1.11
- P/E Ratio
- MTR $18.31
- TXMD N/A
- Revenue Growth
- MTR N/A
- TXMD N/A
- 52 Week Low
- MTR $5.60
- TXMD $0.70
- 52 Week High
- MTR $11.99
- TXMD $2.61
- Technical
- Relative Strength Index (RSI)
- MTR 51.57
- TXMD 35.13
- Support Level
- MTR $6.18
- TXMD $0.75
- Resistance Level
- MTR $6.54
- TXMD $0.91
- Average True Range (ATR)
- MTR 0.08
- TXMD 0.11
- MACD
- MTR 0.03
- TXMD -0.01
- Stochastic Oscillator
- MTR 61.11
- TXMD 3.17
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.